International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study

• Main Authors: Fanny Ofek (Author), Dana Barchel (Author), Nofar Perets (Author), Tomer Ziv-Baran (Author), Ahmad Mahajna (Author), Talia Filipovich-Rimon (Author), Osnat Garach-Jehoshua (Author), Maya Berlin (Author), Matitiahu Berkovitch (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The validity of the common global clotting tests, prot...